Product Code: RP-ID-10352078 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10352078
Market Overview:
Global Anticoagulants and Antiplatelet Agents or Blood Thinners Market Analysis & Outlook 2030
Anticoagulants and antiplatelet agents or blood thinners are drugs that eliminate the risk of thrombosis in blood vessels or the heart. These clots are harmful and can hinder blood circulation in the body, leading to heart attacks and strokes. However, the working process of anticoagulation and antiplatelet is different. On the one hand, antiplatelets interfere with the coagulation process, and on the other hand, anticoagulants interfere with the factors involved in the coagulation process. Doctors recommend the use of anticoagulants and antiplatelet drugs under medical conditions such as atrial fibrillation, deep vein thrombosis (DVT), myocardial infarction, pulmonary embolism, and stroke. Each drug has its effects and side effects, depending on the suitability of the dosage. .
Doctors only prescribe blood thinners when there is a high possibility of thrombosis. According to a report released by Kenneth Market Research, the global anticoagulant drugs market is expected to raise USD 40 billion by 2030 expected to expand at a compound annual growth rate of 8% between 2022 and 2030. Factors such as venous thromboembolism (VTE) and increased prevalence of cardiovascular disease, rapid adoption of new oral anticoagulants (NOACS), and increased awareness of NOAC in emerging economies have driven the adoption and recommendation of anticoagulant drugs.
Stimulated platelets and damaged tissue excrete chemicals that react with factors. Chemical reactions convert factors into solid proteins, which trap blood cells and platelets to form solid clots. However, to balance, there are chemicals in the blood that prevent and dissolve clots. Although blood clot formation requires blood vessel damage, sometimes blood clot formation occurs even if the blood vessel is not damaged. In addition, blood thinners act on vitamin K, which promotes blood clotting by increasing the time required to produce fibrin.
There are several serious diseases that require anticoagulants:
Pulmonary embolism-this is a deep vein thrombosis that occurs when one of the blood vessels supplying the lungs is blocked-this usually occurs in the legs, when a blood clot forms in a stroke: In this case, the blood clot restricts blood from reaching the brain, causing the death of blood cells and causing permanent brain damage or death. Transient ischemic attack (TIA): Also called "cerebrovascular accident" because its symptoms are similar to strokes. : Heart attack: Due to a blood clot, blood vessels stop supplying blood to the heart, thereby reducing oxygen levels, causing chest pain and sometimes death. A clot in the upper chamber of the heart obstructs blood flow, causing arrhythmia and other heart complications. The blood thinners in the above cases can prevent the thrombosis from getting bigger.
However, the intake of blood thinners depends on the type of disease, including long-term disease and short-term disease. On the other hand, anticoagulants cannot be used like other drugs, and several conditions should be considered before use. Blood thinners can be administered orally or by injection. The most commonly used blood thinner is warfarin. However, there are few newer anticoagulants, including rivaroxaban, dabigatran, apixaban, edoxaban, and heparin. Warfarin is the oldest anticoagulant drug, and several other alternative drugs have been invented as alternative drugs. Newer drugs make it easier for patients to reduce the number of regular doctor visits.
Warfarin and a new anticoagulant for the treatment of blood clotting:
A study found that newer blood clotting drugs are better, beneficial and less risky than the old warfarin. Researchers from the University of Nottingham, in collaboration with the National Institutes of Health, studied the benefits and risks of the old warfarin and the more common new drugs direct oral anticoagulants (DOAC), which are called direct oral anticoagulants (DOAC). ), including dabigatran, rivaroxaban and apixaban. In addition, the researchers found that compared with warfarin, apixaban has a lower risk of major bleeding, especially cerebral hemorrhage and stomach hemorrhage. On the other hand, it has been observed that dabigatran can reduce the risk of cerebral hemorrhage in patients with atrial fibrillation, while rivaroxaban can reduce the risk of cerebral hemorrhage in patients with non-AF. In addition, compared with warfarin, low-dose rivaroxaban and apixaban are associated with an increased risk of all-cause death in patients. According to researchers, apixaban has a lower risk of severe bleeding and is the safest drug.
Consider using blood thinners:
Doctors should consider other medical conditions before prescribing blood thinners. However, it is important to inform your doctor about the other treatments you are receiving.
The following are some medical conditions to consider before taking blood thinners:
Pregnancy: Avoid using blood thinners during pregnancy because it can affect the fetus. It can cause excessive bleeding in the uterus. However, sometimes it may be recommended to take it in the second trimester.
Other medicines: While taking blood thinners, you need to take other medicines to prevent doctors from worrying. Some drugs can change blood thinners or increase their effects, which may be risky. Diet: Food considers that vitamin K will interfere with the function of warfarin. Therefore, patients should follow the diet recommended by the doctor. Other injuries: Be careful when cutting objects and playing outdoor games. Using insect spray can also avoid insect bites. The use of blood thinners is subtle and requires a lot of consideration. On the other hand, blood thinners also have various side effects. The main side effects of blood thinners include excessive bleeding in the form of menorrhagia, blood in the urine or stool, nosebleeds, bleeding gums, and prolonged bleeding from wounds and wounds. In addition, patients may experience diarrhea, dizziness, indigestion, headache, nausea, itching, hair loss and jaundice. However, if used as prescribed, blood thinners can provide good health.
Related Reports
Proof of Quality & Reliability
